Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Alpha 1 for Prevention of Pancreatic Infection in Acute Necrotizing Pancreatitis
NCT02473406Phase 4Completed
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of thymosin alpha 1 in acute necrotizing pancreatitis (ANP). Started Mar 2018; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
acute necrotizing pancreatitis (ANP)
Beyond the preview
Go deeper on NCT02473406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473406.